Healthcare

Global Rheumatoid Arthritis Drugs Market 2014-2018

  • TEC20241
  • 94 Pages
  • July 2014
  • Healthcare
About Rheumatoid Arthritis
RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.
TechNavio's analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Rheumatoid Arthritis Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of RA that are available in the market. The Global Rheumatoid Arthritis Drugs market can be divided into two segments: Symptomatic and DMARDs.
TechNavio's report, the Global Rheumatoid Arthritis Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Rheumatoid Arthritis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
AbbVie Inc.
Amgen Inc.
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Janssen Pharmaceuticals Inc.
Pfizer Inc.
Other Prominent Vendors

AB Science SA
Astellas Pharma Inc.
AstraZeneca plc
Biogen Idec Inc.
Boehringer Ingelheim GmbH
Celgene Corp.
Daiichi Sankyo Co. Ltd.
Eli Lilly & Co.
GE Healthcare Co.
Genmab A/S
GSK plc
Incyte Corp.
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corp.
Novartis AG
Novo Nordisk A/S
Rigel Pharmaceuticals Inc.
Sanofi
Takeda Pharmaceutical Co. Ltd.
UCB SA
Vertex Pharmaceuticals Inc.
Key Market Driver
Increasing Aging Population
For a full, detailed list, view our report.
Key Market Challenge
High Cost of RA Treatment
For a full, detailed list, view our report.
Key Market Trend
Increase in R&D Activities
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

U.S. NPWT Devices Market - Opportunities and Forecast, 2015 - 2020

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Asian Chromatography Solvents Market - Opportunities and Forecasts, 2015 - 2020

Chromatography is a technique used for separation of mixtures for advanced use. Chromatography solvents, such as methanol, chloroform, ethanol, and others are used for separation of mixtures. One component solvent ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Intra-Dialytic Hypotension (IDH) Asia-Pacific Market Research Report, 2013 - 2020

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ≥20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

European Dermatology Diagnostic Devices Market- Opportunities and Forecasts, 2014 - 2020

The healthcare sector across Europe is witnessing a dramatic shift and is inclined towards less invasive diagnostic procedures. Dermatology diagnostic equipment aids in both easy as well as painless diagnosis. ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>